Novo: In Redefine 9, Cagrisema 1.0 Mg/1.0 Mg Provided A Weight Reduction Of 21.0% Versus 2.0% For Placebo, And Primary Superiority Endpoint Was Met
Novo: In Redefine 9, Cagrisema 1.0 Mg/1.0 Mg Provided A Weight Reduction Of 21.0% Versus 2.0% For Placebo, And Primary Superiority Endpoint Was Met